Skip to content

US · WAY · MEDICAL - HEALTHCARE INFORMATION SERVICES

Waystar Holding Corp. (WAY) intrinsic value and stock valuation

$26.52as of 2026-11-21 · Mkt cap 4.65B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Waystar Holding Corp. DCF and intrinsic value

InvestorsCraft values WAY with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from WAY’s statements →

Waystar Holding Corp. Graham Number

Graham Number: $17.58d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Lehi, UT 84043 waystar.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$1.1B
20212025
Net income
$112.1M
20212025
Free cash flow
$283.2M
20212025
Total equity
$3.88B
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$1.1B$943.6M$791M$704.9M$578.6M
Operating income$249.3M$123.7M$142.1M$89.5M$60.3M
Net income$112.1M-$-19.12M-$-51.33M-$-51.45M-$-47.12M
EPSd$606.6K-$-127.53K-$-307.99K-$-308.71K-$-282.73K
Operating cash flow$309.7M$169.8M$51.5M$102.6M$106.4M
Capital expenditure-$-26.48M-$-27.27M-$-21.52M-$-17.43M-$-14.54M
Free cash flow$283.2M$142.5M$29.9M$85.2M$91.9M
Total assets$5.79B$4.58B$4.58B$4.69B$4.78B
Total debt$1.49B$1.26B$2.25B$2.26B$2.3B
Net debt$1.43B$1.08B$2.21B$2.2B$2.25B
Total equity$3.88B$3.08B$2.05B$2.11B$2.12B
Cash and short-term investments$86.2M$182.1M$35.6M$64.6M$47.3M
Income statement
20252024202320222021
Revenue$1.1B$943.6M$791M$704.9M$578.6M
Cost of revenue$348.2M$315.7M$249.8M$214.9M$151.8M
Gross profit$751.1M$627.8M$541.2M$490M$426.8M
Research and development expenses$54.6M$48.8M$35.3M$32.8M$28.3M
Selling, general and administrative expenses$306.6M$268.7M$187.4M$184.6M$162.1M
Other expenses$140.6M$186.6M$176.5M$183.2M$176.1M
Operating expenses$501.8M$504.1M$399.2M$400.5M$366.5M
Cost and expenses$850M$819.8M$648.9M$615.4M$518.3M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$77.5M$146.3M$205.9M$155.3M$127M
Depreciation and amortization$140.6M$186.6M$176.5M$183.2M$176.1M
Ebitda$389.9M$310.4M$318.6M$272.6M$236.4M
Operating income$249.3M$123.7M$142.1M$89.5M$60.3M
Total other income/expenses, net-$-77.54M-$-146.27M-$-205.92M-$-155.32M-$-127.01M
Income before tax$171.8M-$-22.55M-$-63.83M-$-65.88M-$-66.7M
Income tax expense$59.7M-$-3.42M-$-12.5M-$-14.42M-$-19.58M
Net income$112.1M-$-19.12M-$-51.33M-$-51.45M-$-47.12M
Weighted average shares outstanding$177.9M$149.9M$166.7M$166.7M$166.7M
Weighted average diluted shares outstanding$184.8M$149.9M$166.7M$166.7M$166.7M
Balance sheet
20252024202320222021
Cash and short-term investments$86.2M$182.1M$35.6M$64.6M$47.3M
Net receivables$183.5M$148.1M$132.9M$111.4M$103M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$308.4M$371M$222.1M$217.9M$166.9M
Property, plant and equipment, net$64.6M$57.6M$71.6M$67.6M$58.6M
Goodwill and intangible assets$5.31B$4.06B$4.22B$4.34B$4.5B
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$5.48B$4.21B$4.36B$4.48B$4.61B
Total assets$5.79B$4.58B$4.58B$4.69B$4.78B
Accounts payable$51M$47.4M$45.5M$28.1M$34.8M
Short-term debt$20.2M$18.2M$23.2M$22.8M$18.7M
Deferred revenue$67.9M$10.5M$10.9M$9.9M$11.7M
Total current liabilities$218.1M$145.6M$123.5M$102.2M$110.3M
Long-term debt$1.47B$1.25B$2.23B$2.24B$2.28B
Deferred revenue, non-current$5.5M$5.74M$6.17M$6.55M$6.07M
Total non-current liabilities$1.69B$1.35B$2.41B$2.49B$2.55B
Capital lease obligations$18M$30.9M$31.7M$35.5M$14.5M
Total liabilities$1.91B$1.5B$2.53B$2.59B$2.66B
Common stock$1.92M$1.72M$1.22M$1.22M$2.01M
Retained earnings-$-108.81M-$-220.9M-$-201.78M-$-150.44M-$-98.99M
Accumulated other comprehensive income (loss)-$-630K$880K$15.8M$29.8M-$-490K
Total equity$3.88B$3.08B$2.05B$2.11B$2.12B
Total investments$24.9M$0.00$0.00$0.00$0.00
Total debt$1.49B$1.26B$2.25B$2.26B$2.3B
Net debt$1.43B$1.08B$2.21B$2.2B$2.25B
Cash flow statement
20252024202320222021
Net income$112.1M-$-19.12M-$-51.33M-$-51.45M-$-47.12M
Depreciation and amortization$140.6M$186.6M$176.5M$183.2M$176.1M
Stock-based compensation$42.1M$54.4M$8.85M$8M$6.83M
Change in working capital-$-38.09M-$-20.17M-$-34.62M-$-34.78M-$-18.81M
Accounts receivable-$-24.32M-$-17.84M-$-19.17M-$-10.94M-$-12.66M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$8.93M$18.2M$11.9M$0.00$0.00
Net cash provided by operating activities$309.7M$169.8M$51.5M$102.6M$106.4M
Investments in property, plant and equipment-$-26.48M-$-27.27M-$-21.52M-$-17.43M-$-14.54M
Acquisitions, net-$-629.53M$0.00-$-40M$0.00-$-429.79M
Net cash used for investing activities-$-680.9M-$-27.27M-$-61.52M-$-17.43M-$-444.33M
Common stock issued$25.8M$1.02B$420K$650K$1.19M
Common stock repurchased$0.00-$-840K-$-690K-$-2.45M-$-1.91M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$243.5M$16.7M-$-17.15M-$-67.06M$331.5M
Net change in cash-$-127.77M$159.2M-$-27.21M$18.1M-$-6.43M
Cash at end of period$76.8M$204.6M$45.4M$72.6M$54.5M
Operating cash flow$309.7M$169.8M$51.5M$102.6M$106.4M
Capital expenditure-$-26.48M-$-27.27M-$-21.52M-$-17.43M-$-14.54M
Free cash flow$283.2M$142.5M$29.9M$85.2M$91.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Waystar Holding Corp.

        Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.

        CEO
        Matthew J. Hawkins
        Employees
        1.7K
        Beta
        0.07

        Explore

        Frequently asked questions

        What is the intrinsic value of Waystar Holding Corp. (WAY)?

        Waystar Holding Corp. (WAY) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is WAY undervalued?

        WAY trades at a price of $26.52 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.